On the evening of December 23, the first GLP-1 dual-target drug Tirzepatide (Mounjaro) was launched for a limited time on Meituan, and sources close to Meituan revealed that it sold out in 3 seconds on the first night, with the booking volume increasing more than three times daily. Currently, supply is gradually catching up with demand, and it has been available for purchase all day since December 25. Customer service representatives stated that Tirzepatide is in high demand, and they will continue to stock up to meet the demand. Reports indicate that the supply may stabilize starting from January to February.